Who owns TRAVERE THERAPEUTICS INC (TVTX?
- CUSIP Number: 89422gaa5
Tip: Access positions for across all investors
Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Travere Therapeutics stock
Who bought or sold TRAVERE THERAPEUTICS INC (TVTX this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 86M | $122M | -5% | Dec 2025 |
|
| Context Capital Management | 53M | $67M | -8% | Mar 2026 |
|
| D. E. Shaw & Co | 38M | $48M | 0% | Mar 2026 |
|
| Tenor Capital Management | 32M | $40M | 133% | Mar 2026 |
|
| FMR | 30M | $43M | 705% | Dec 2025 |
|
| Advent Capital Management | 17M | $22M | 22% | Mar 2026 |
|
| Graham Capital Management | 17M | $21M | 100% | Mar 2026 |
|
| Shenkman Capital Management | 9.7M | $12B | 45% | Mar 2026 |
|
| Lord, Abbett & Co | 9.1M | $12M | -33% | Mar 2026 |
|
| Affinity Asset Advisors | 7.0M | $10M | 0% | Dec 2025 |
|
| M&G | 5.1M | $6.5M | 0% | Mar 2026 |
|
| BlackRock | 5.0M | $6.3M | 35% | Mar 2026 |
|
| Henderson Group | 4.8M | $6.0M | -25% | Mar 2026 |
|
| Goldman Sachs Group | 4.7M | $5.9M | -21% | Mar 2026 |
|
| Two Sigma Investments | 3.0M | $3.8M | 100% | Mar 2026 |
|
| Polar Capital Holdings | 2.5M | $3.5M | -69% | Dec 2025 |
|
| Gabelli Funds | 2.4M | $3.4M | 100% | Dec 2025 |
|
| Agf Management | 1.6M | $2.0M | 48% | Mar 2026 |
|
| UBS Group | 1.2M | $1.5M | 100% | Mar 2026 |
|
| Kohlberg Kravis Roberts & Co | 860k | $1.1M | -57% | Mar 2026 |
|
| Union Bancaire Privee, UBP SA | 325k | $342k | 100% | Mar 2026 |
|
| Jane Street | 300k | $380k | 100% | Mar 2026 |
|
| GAMCO Asset Management | 250k | $352k | 100% | Dec 2025 |
|
| Barclays | 155k | $221k | 100% | Dec 2025 |
|
| Royal Bank of Canada | 71k | $107k | 100% | Mar 2026 |
|
| Citigroup | 50k | $63k | 100% | Mar 2026 |
|
| Leucadia National Corporation | 45k | $57k | 309% | Mar 2026 |
|
| Branch Banking & Trust Company | 41k | $52k | 0% | Mar 2026 |
|
| Wiley Bros.-aintree Capital | 16k | $23k | 0% | Dec 2025 |
|
| Goss Wealth Management | 13k | $13k | -38% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 2.0k | $2.5k | 0% | Mar 2026 |
|
Who sold out of Travere Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Dec 2025 | 16M | $23M |
| Point72 Asset Management | Dec 2025 | 4.0M | $5.7M |
| Capstone Investment Advisors | Dec 2025 | 1.0M | $1.4M |
| Toronto-Dominion Bank | Sep 2025 | 811k | $925k |
| New York State Common Retirement Fund | Dec 2025 | 800k | $1.1M |
| Jpmorgan Chase & Co | Sep 2025 | 556k | $634k |